Edgewise Therapeutics (EWTX) Competitors

Edgewise Therapeutics (NASDAQ:EWTX) and Dyne Therapeutics (NASDAQ:DYN) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Which has better valuation & earnings, EWTX or DYN?

Edgewise Therapeutics is trading at a lower price-to-earnings ratio than Dyne Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edgewise Therapeutics	N/A	N/A	-$100.16M	-$1.50	-21.30
Dyne Therapeutics	N/A	N/A	-$235.94M	-$3.56	-8.42

Is EWTX or DYN more profitable?

Edgewise Therapeutics' return on equity of -26.83% beat Dyne Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edgewise Therapeutics	N/A	-26.83%	-25.67%
Dyne Therapeutics	N/A	-57.46%	-51.62%

Do insiders & institutionals have more ownership in EWTX or DYN?

96.7% of Dyne Therapeutics shares are owned by institutional investors. 24.1% of Edgewise Therapeutics shares are owned by insiders. Comparatively, 20.8% of Dyne Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Do analysts rate EWTX or DYN?

Edgewise Therapeutics currently has a consensus price target of $38.40, suggesting a potential upside of 20.19%. Dyne Therapeutics has a consensus price target of $51.40, suggesting a potential upside of 71.39%. Given Dyne Therapeutics' higher possible upside, analysts plainly believe Dyne Therapeutics is more favorable than Edgewise Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edgewise Therapeutics	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Dyne Therapeutics	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has more volatility and risk, EWTX or DYN?

Edgewise Therapeutics has a beta of 0.14, suggesting that its stock price is 86% less volatile than the S&P 500. Comparatively, Dyne Therapeutics has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.

Does the media refer more to EWTX or DYN?

In the previous week, Dyne Therapeutics had 12 more articles in the media than Edgewise Therapeutics. MarketBeat recorded 18 mentions for Dyne Therapeutics and 6 mentions for Edgewise Therapeutics. Edgewise Therapeutics' average media sentiment score of 0.66 beat Dyne Therapeutics' score of -0.10 indicating that Edgewise Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edgewise Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Dyne Therapeutics	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer EWTX or DYN?

Edgewise Therapeutics received 2 more outperform votes than Dyne Therapeutics when rated by MarketBeat users. Likewise, 72.09% of users gave Edgewise Therapeutics an outperform vote while only 70.73% of users gave Dyne Therapeutics an outperform vote.

Company	Underperform	Outperform
Edgewise Therapeutics	Outperform Votes 31 72.09%	Underperform Votes 12 27.91%
Dyne Therapeutics	Outperform Votes 29 70.73%	Underperform Votes 12 29.27%

Summary

Edgewise Therapeutics beats Dyne Therapeutics on 8 of the 15 factors compared between the two stocks.